Cell-in-cell:an emerging player in COVID-19 and immune disorders  

作　　者：Qiang Sun Wei Chen 

机构地区：[1]Beijing Institute of Biotechnology,Academy of Military Medical Sciences,Beijing 100071,China [2]Research Unit of Cell Death Mechanism,Chinese Academy of Medical Sciences,Beijing 100071,China

出　　处：《National Science Open》2022年第1期2-7,共6页国家科学进展（英文）

基　　金：supported by the National Natural Science Foundation of China(31970685).

摘　　要：Cell-in-cell is a unique phenomenon mostly documented in human cancer tissues.A recent study demonstrated that cell-in-cell might promote lymphopenia by internalizing and killing immune cells in COVID-19,which implicates cell-in-cell as an emerging player in a broader spectrum of pathological processes,such as immune dysregulation.

关 键 词：cell-in-cell cell death COVID-19 LYMPHOPENIA immune dysregulation 

分 类 号：R73[医药卫生—肿瘤]